Our company puts a large sum of money into SECP scientific research and clinical practice; collecting a large amount of data settles a firm basis for newly SECP successful outcome. Furthermore, Our company owns a serious of ECP experts, which guarantees the ECP development.
Our SECP therapy systems is leading a new concept of nonivasive treatment for patients with cardiac and cerebral ischemic disease.
Company Profile
-
Established in2003
-
Business types
- Exporter/Agent
-
Markets
-
East Europe / Russia / East Asia / Southeast Asia / Mid-East / Africa / Australia / New Zealand